Literature DB >> 28899815

Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice.

Zhiyuan Wen1, Xi Wang2, Ke Dong2, Huizhong Zhang3, Zhigao Bu4, Ling Ye5, Chinglai Yang6.   

Abstract

Elderly humans over 65 years old are at great risk to pathogenesis by influenza virus infection. However, although influenza vaccines provide effective protection in healthy young adults, protection of elderly adults is substantially lower even with a good match between the vaccine and the circulating influenza virus. To gain insight of the underlying mechanism for the reduced immunogenicity of influenza vaccines in the aged population, we investigated immunogenicity of influenza virus-like particle vaccines in aged mice, which represent a useful model for studying aging associated impairment in immune responses. Specifically, we investigated the effect of inhibiting regulatory T cells in aged mice on induction of protective immune responses by influenza vaccines. Our results showed that injecting anti-CD25 antibodies could down-regulate CD25 on the surface of regulatory T cells and significantly increase the levels of antibody responses induced by VLP immunization in aged mice. Further, the profiles of antibody responses were also changed towards Th1 type by regulatory T cell blockage in aged mice. Moreover, aged mice that were treated by anti-CD25 antibodies prior to vaccination were more effectively protected against lethal influenza virus challenge.
Copyright © 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aging; Influenza; Regulatory T cell; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28899815      PMCID: PMC5726911          DOI: 10.1016/j.micinf.2017.08.013

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  50 in total

Review 1.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

Review 2.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

3.  Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.

Authors:  Ling Ye; Zhigao Bu; Andrei Vzorov; Dahnide Taylor; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 4.  Aging and impaired immunity to influenza viruses: implications for vaccine development.

Authors:  Wai Ming Liu; Bernard A M van der Zeijst; Claire J P Boog; Ernst C Soethout
Journal:  Hum Vaccin       Date:  2011-01-01

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

Review 7.  Understanding immunosenescence to improve responses to vaccines.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Immunol       Date:  2013-04-18       Impact factor: 25.606

8.  Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Authors:  Adam P Kohm; Jeffrey S McMahon; Joseph R Podojil; Wendy Smith Begolka; Mathew DeGutes; Deborah J Kasprowicz; Steven F Ziegler; Stephen D Miller
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

9.  Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.

Authors:  W J Bean; M Schell; J Katz; Y Kawaoka; C Naeve; O Gorman; R G Webster
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  New world bats harbor diverse influenza A viruses.

Authors:  Suxiang Tong; Xueyong Zhu; Yan Li; Mang Shi; Jing Zhang; Melissa Bourgeois; Hua Yang; Xianfeng Chen; Sergio Recuenco; Jorge Gomez; Li-Mei Chen; Adam Johnson; Ying Tao; Cyrille Dreyfus; Wenli Yu; Ryan McBride; Paul J Carney; Amy T Gilbert; Jessie Chang; Zhu Guo; Charles T Davis; James C Paulson; James Stevens; Charles E Rupprecht; Edward C Holmes; Ian A Wilson; Ruben O Donis
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  4 in total

Review 1.  The Complex Role of Regulatory T Cells in Immunity and Aging.

Authors:  Lourdes Rocamora-Reverte; Franz Leonard Melzer; Reinhard Würzner; Birgit Weinberger
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 8.786

2.  Depletion of CD38-positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV-2 vaccination in patients with plasma cell dyscrasia.

Authors:  Toshiki Terao; Takashi Naduka; Daisuke Ikeda; Ami Fukumoto; Yuya Kamura; Ayumi Kuzume; Rikako Tabata; Takafumi Tsushima; Daisuke Miura; Kentaro Narita; Masami Takeuchi; Kosei Matsue
Journal:  Br J Haematol       Date:  2022-02-16       Impact factor: 8.615

Review 3.  The dark side of Tregs during aging.

Authors:  Martina Palatella; Stephane M Guillaume; Michelle A Linterman; Jochen Huehn
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

Review 4.  Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly.

Authors:  Weikan Wang; Rachel Thomas; Jiyoung Oh; Dong-Ming Su
Journal:  Cells       Date:  2021-03-12       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.